These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 34183017)

  • 21. Nicotinamide adenine dinucleotide treatment alleviates the symptoms of experimental autoimmune encephalomyelitis by activating autophagy and inhibiting the NLRP3 inflammasome.
    Wang X; Li B; Liu L; Zhang L; Ma T; Guo L
    Int Immunopharmacol; 2021 Jan; 90():107092. PubMed ID: 33290962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
    Berghmans N; Heremans H; Li S; Martens E; Matthys P; Sorokin L; Van Damme J; Opdenakker G
    J Neuroinflammation; 2012 Oct; 9():243. PubMed ID: 23095573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of aryl hydrocarbon receptor signaling by a novel agonist ameliorates autoimmune encephalomyelitis.
    Abdullah A; Maged M; Hairul-Islam M I; Osama I A; Maha H; Manal A; Hamza H
    PLoS One; 2019; 14(4):e0215981. PubMed ID: 31026283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel PADRE-Kv1.3 vaccine effectively induces therapeutic antibodies and ameliorates experimental autoimmune encephalomyelitis in rats.
    Fan C; Long R; You Y; Wang J; Yang X; Huang S; Sheng Y; Peng X; Liu H; Wang Z; Liu K
    Clin Immunol; 2018 Aug; 193():98-109. PubMed ID: 29496642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System.
    Thomé R; de Carvalho AC; Alves da Costa T; Ishikawa LL; Fraga-Silva TF; Sartori A; de Oliveira AL; Verinaud L
    CNS Neurosci Ther; 2016 Aug; 22(8):707-14. PubMed ID: 27165523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The kinetics of myelin antigen uptake by myeloid cells in the central nervous system during experimental autoimmune encephalomyelitis.
    Sosa RA; Murphey C; Ji N; Cardona AE; Forsthuber TG
    J Immunol; 2013 Dec; 191(12):5848-57. PubMed ID: 24227784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alteration of the cytokine signature by various TLR ligands in different T cell populations in MOG37-50 and MOG35-55-induced EAE in C57BL/6 mice.
    Steckner C; Weber A; Mausberg AK; Heininger M; Opdenhövel F; Kieseier BC; Hartung HP; Hofstetter HH
    Clin Immunol; 2016 Sep; 170():22-30. PubMed ID: 27233983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
    Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
    J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic effect of the total saponin from Panax Japonicus on experimental autoimmune encephalomyelitis by attenuating inflammation and regulating gut microbiota in mice.
    Wang J; He L; Wang S; Zhao H; Chen J; Dong Y; Yasen S; Wang L; Zou H
    J Ethnopharmacol; 2023 Oct; 315():116681. PubMed ID: 37230280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-7Rα on CD4
    Azizi G; Van den Broek B; Ishikawa LLW; Naziri H; Yazdani R; Zhang GX; Ciric B; Rostami A
    J Neuroinflammation; 2024 Oct; 21(1):253. PubMed ID: 39380064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
    Sonobe Y; Jin S; Wang J; Kawanokuchi J; Takeuchi H; Mizuno T; Suzumura A
    Tohoku J Exp Med; 2007 Dec; 213(4):329-39. PubMed ID: 18075237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of Indoleamine-2,3-Dioxygenase and Kynurenine Pathway in Experimental Autoimmune Encephalomyelitis in Mice.
    Zarzecki MS; Cattelan Souza L; Giacomeli R; Silva MRP; Prigol M; Boeira SP; Jesse CR
    Neurochem Res; 2020 Dec; 45(12):2959-2977. PubMed ID: 33040279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High Dimensional Cytometry of Central Nervous System Leukocytes During Neuroinflammation.
    Mrdjen D; Hartmann FJ; Becher B
    Methods Mol Biol; 2017; 1559():321-332. PubMed ID: 28063054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms.
    Moransard M; Bednar M; Frei K; Gassmann M; Ogunshola OO
    J Neuroinflammation; 2017 Oct; 14(1):202. PubMed ID: 29029628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LFA-1 Controls Th1 and Th17 Motility Behavior in the Inflamed Central Nervous System.
    Dusi S; Angiari S; Pietronigro EC; Lopez N; Angelini G; Zenaro E; Della Bianca V; Tosadori G; Paris F; Amoruso A; Carlucci T; Constantin G; Rossi B
    Front Immunol; 2019; 10():2436. PubMed ID: 31681316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice for the longitudinal study of pathology and repair.
    Hasselmann JPC; Karim H; Khalaj AJ; Ghosh S; Tiwari-Woodruff SK
    J Neurosci Methods; 2017 Jun; 284():71-84. PubMed ID: 28396177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of adaptive immunity by the fractalkine receptor during autoimmune inflammation.
    Garcia JA; Pino PA; Mizutani M; Cardona SM; Charo IF; Ransohoff RM; Forsthuber TG; Cardona AE
    J Immunol; 2013 Aug; 191(3):1063-72. PubMed ID: 23817416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-33 deficiency exacerbated experimental autoimmune encephalomyelitis with an influence on immune cells and glia cells.
    Xiao Y; Lai L; Chen H; Shi J; Zeng F; Li J; Feng H; Mao J; Zhang F; Wu N; Xu Y; Tan Z; Gong F; Zheng F
    Mol Immunol; 2018 Sep; 101():550-563. PubMed ID: 30173119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Notch signaling regulates T cell accumulation and function in the central nervous system during experimental autoimmune encephalomyelitis.
    Sandy AR; Stoolman J; Malott K; Pongtornpipat P; Segal BM; Maillard I
    J Immunol; 2013 Aug; 191(4):1606-13. PubMed ID: 23825310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deletion of indoleamine 2,3 dioxygenase (Ido)1 but not Ido2 exacerbates disease symptoms of MOG
    Wetzel LA; Hurtado M; MacDowell Kaswan ZA; McCusker RH; Steelman AJ
    Brain Behav Immun Health; 2020 Aug; 7():100116. PubMed ID: 34589873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.